Mucolytics
Mucolytic therapy should be stopped if there is no benefit after a 4 week trial.
Mucolytics may disrupt the gastric mucosal barrier - caution in patients with history of peptic ulceration.
Acetylcysteine 600mg effervescent tablets are not suitable for any patient who has a sodium restricted diet, and use with caution in patients who are concomitantly using Glyceryl trinitrate
Capsules should not be dispensed as they are more expensive than the tablets.
MTW-approved for the following off-label specialist uses:
- prevention of contrast media induced nephropathy
- pulmonary fibrosis
| Pack |
|---|
| 20 tablet (2 x 10 tablets) |
| 30 tablet (5 x 6 tablets) |
Restricted to off-label use by respiratory consultants only
| Pack |
|---|
| 10 ampoule |
| Pack |
|---|
| 120 capsule |
| 30 capsule |
| Pack |
|---|
| 125 ml |
| 250 ml |
| 300 ml |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary